Latest News for: Eisai
Edit
Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi
PR Newswire 22 Apr 2026
The GHIT Fund has been investing in a collaboration between Eisai Co., Ltd ... Eisai Co., Ltd ... TropIQ Health Sciences (TropIQ) will lead a primary screen of compounds from Eisai Co., Ltd.'s (Eisai) compound library using a probe-based biochemical assay.
Edit
Enid News & Eagle
21 Apr 2026
Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for ...
Edit
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 ...
JCN Newswire 21 Apr 2026
Edit
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
New York Times 16 Apr 2026
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments ... .
Edit
Eisai to Present the Latest Data on Real-World Treatment with Lecanemab and Supporting a Standardized Framework for Treating Early Alzheimer's Disease at the 78th American Academy of Neurology's Annual Meeting
PR Newswire 09 Apr 2026
Edit
Eisai Co., Ltd. Shelf Registration Preliminary Rating Assigned AA- (R&I - Rating and Investment Information Inc)
Public Technologies 08 Apr 2026
Edit
An Insider’s Guide to Where to Stay, Eat and Explore in Kyoto, Japan
New York Observer 07 Apr 2026
The monk Eisai founded this temple in 1202 and proceeded to introduce both Zen Buddhism and tea cultivation to Japan, which makes Kennin-ji arguably the most consequential piece of real estate in Gion.
Edit
Brattleboro Reformer
27 Mar 2026
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ...
The Marketing Authorisation Application (MAA) has been validated and accepted for full approval consideration with a standard review timeline ....
Edit
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
PR Newswire 26 Mar 2026
Edit
Rocky Mount Telegram
21 Mar 2026
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at ...
Edit
Eisai: Regarding Discontinuation of Administration of "Tazverik(R) Tablets 200mg" (tazemetostat hydrobromide)
JCN Newswire 19 Mar 2026
Edit
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations ...
JCN Newswire 17 Mar 2026
TOKYO, Mar 17, 2026 - (JCN Newswire) - Eisai Co., Ltd ... The Centre serves as Eisai’s information technology hub ... Eisai established “Eisai Knowledge Centre, India, in Andhra Pradesh in 2009 ... Eisai Co., Ltd.
Edit
Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration
JCN Newswire 12 Mar 2026
TOKYO, Mar 12, 2026 - (JCN Newswire) - Eisai Co., Ltd ... This initiative is part of Eisai’s efforts to build an ecosystem in the sleep field, a key focus area for the company ... Eisai Co., Ltd ... About the Sleep Information Website Operated by Eisai.
- 1
- 2
- Next page »